Oxidized Low Density Lipoprotein (OX-LDL) Induced Arterial Muscle Contraction Signaling Mechanisms



C. Subah Packer1, *, Ami E. Rice1, Tomalyn C. Johnson1, Nancy J. Pelaez4, Constance J. Temm2, George V. Potter1, William A. White1, Alan H. Roth1, Jesus H. Dominguez2, Richard G. Peterson3, 5
1 Departments of Cellular & Integrative Physiology, Indiana University School of Medicine, Indianapolis, Indiana 46202
2 Medicine (Nephrology), Indiana University School of Medicine, Indianapolis, Indiana 46202
3 Anatomy & Cell Biology, Indiana University School of Medicine, Indianapolis, Indiana 46202
4 Department of Biological Sciences, Purdue University
5 PreClinOmics (PCO), Inc., USA


Article Metrics

CrossRef Citations:
0
Total Statistics:

Full-Text HTML Views: 133
Abstract HTML Views: 218
PDF Downloads: 163
Total Views/Downloads: 514
Unique Statistics:

Full-Text HTML Views: 91
Abstract HTML Views: 137
PDF Downloads: 121
Total Views/Downloads: 349



© 2014 Packer et al.

open-access license: This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: https://creativecommons.org/licenses/by/4.0/legalcode. This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

* Address correspondence to this author at the PreClinOmics (PCO), 7918 Zionsville Road, Indianapolis, IN 46268, USA; Tel: 317-872-6001; Fax: 317-872-6002; E-mail: cspacker@preclinomics.com


Abstract

Oxidized low-density lipoprotein cholesterol (OX-LDL), a reactive oxidant, forms when reactive oxygen species interact with LDL. Elevated OX-LDL may contribute to high blood pressure associated with diseases such as diabetes and obesity. The current study objective was to determine if OX-LDL is a vasoconstrictor acting through the OX-LDL receptor (LOX1) on arterial smooth muscle and elucidate the intracellular signaling mechanism. Arteries were extracted from Sprague-Dawley rats (SD) and obese F1 offspring (ZS) of Zucker diabetic fatty rats (ZDF) x spontaneously hypertensive heart failure rats (SHHF). Pulmonary arterial and aortic rings and caudal arterial helical strips were attached to force transducers in muscle baths. Arterial preparations were contracted with high KCl to establish maximum force development in response to membrane depolarization (Po). Addition of OX-LDL caused contractions of varying strength dependent on the arterial type. OX-LDL contractions were normalized to % Po. Caudal artery was more reactive to OX-LDL than aorta or pulmonary artery. Interestingly, LOX1 density varied with arterial type in proportion to the magnitude of the contractile response to OX-LDL. OX-LDL contractions in the absence of calcium generated about 50% as much force as in normal calcium. Experiments with myosin light chain kinase and Rho kinase inhibitors, ML-9 and Y-27632, suggest OX-LDL induced contraction is mediated by additive effects of two distinct signaling pathways activated concomitantly in the presence of calcium. Results may impact development of new therapeutic agents to control hypertension associated with disorders in which circulating LDL levels are high in a high oxidizing environment.

Keywords: Arterial smooth muscle, calcium-independent contraction, diabetes, hypertension, oxidized-LDL, vasoactive oxidants.